BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17634114)

  • 1. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
    Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
    BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter cross-talk affects the inducible expression of intronic shRNAs from the tetracycline response element.
    Park SK; Hwang BJ; Kee Y
    Genes Genomics; 2019 Apr; 41(4):483-490. PubMed ID: 30656518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines.
    Henriksen JR; Løkke C; Hammerø M; Geerts D; Versteeg R; Flaegstad T; Einvik C
    Nucleic Acids Res; 2007; 35(9):e67. PubMed ID: 17426119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
    Fish RJ; Kruithof EK
    BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
    Ogueta SB; Yao F; Marasco WA
    Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A versatile tool for conditional gene expression and knockdown.
    Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
    Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of mammalian genes by tetracycline-inducible shRNA expression.
    Kappel S; Matthess Y; Kaufmann M; Strebhardt K
    Nat Protoc; 2007; 2(12):3257-69. PubMed ID: 18079726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
    Aagaard L; Amarzguioui M; Sun G; Santos LC; Ehsani A; Prydz H; Rossi JJ
    Mol Ther; 2007 May; 15(5):938-45. PubMed ID: 17311008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline-dependent inducible and reversible RNA interference mediated by a single lentivirus vector.
    Matsushita N; Matsushita S; Hirakawa S; Higashiyama S
    Biosci Biotechnol Biochem; 2013; 77(4):776-81. PubMed ID: 23563548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
    Schmeisser F; Donohue M; Weir JP
    Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vector-based RNA interference to study gene function in cancer.
    Stovall DB; Wan M; Zhang Q; Dubey P; Sui G
    J Vis Exp; 2012 Jun; (64):e4129. PubMed ID: 22710444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pHUSH: a single vector system for conditional gene expression.
    Gray DC; Hoeflich KP; Peng L; Gu Z; Gogineni A; Murray LJ; Eby M; Kljavin N; Seshagiri S; Cole MJ; Davis DP
    BMC Biotechnol; 2007 Sep; 7():61. PubMed ID: 17897455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1.
    Matthess Y; Kappel S; Spänkuch B; Zimmer B; Kaufmann M; Strebhardt K
    Oncogene; 2005 Apr; 24(18):2973-80. PubMed ID: 15735719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
    Frank SB; Schulz VV; Miranti CK
    BMC Biotechnol; 2017 Feb; 17(1):24. PubMed ID: 28245848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.
    Szulc J; Aebischer P
    Methods Mol Biol; 2008; 434():291-309. PubMed ID: 18470652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene disruption by regulated short interfering RNA expression, using a two-adenovirus system.
    Kuninger D; Stauffer D; Eftekhari S; Wilson E; Thayer M; Rotwein P
    Hum Gene Ther; 2004 Dec; 15(12):1287-92. PubMed ID: 15684704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-vector inducible lentiviral RNAi system for oncology target validation.
    Wiederschain D; Wee S; Chen L; Loo A; Yang G; Huang A; Chen Y; Caponigro G; Yao YM; Lengauer C; Sellers WR; Benson JD
    Cell Cycle; 2009 Feb; 8(3):498-504. PubMed ID: 19177017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.